Company / Cash & Equivalents
Alphatec Holdings, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$160.8M
FY2025
5-year range
$84.7M / $221.0M
FY2021-FY2025
Trend
+15.8%
vs FY2024
Sector context
#92 of 148
Health Care
What the data says
At $161M, Alphatec Holdings, Inc.'s cash & equivalents ranks #92 of 148 in the Health Care sector. Cash & Equivalents has fluctuated over the past 9 years, ranging from $20M in FY2016 to $221M in FY2023.
Based on SEC 10-K filings.
$161M in FY2025 with a 5-year CAGR of +8.3%.
Declined from $221M to $161M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +23.8%
- 5-Year CAGR
- +8.3%
- 10-Year CAGR
- -
Sector benchmark
#92 of 148 in Health CareTop 62% of 148This company $160.8M Sector average $1.2B
▼
-86.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.3%, indicating consistent growth.
- In FY2025, cash & equivalents increased 15.8% year-over-year.
- Ranks #92 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $160.8M | +15.8% |
| FY2024 | $138.8M | -37.2% |
| FY2023 | $221.0M | +160.9% |
| FY2022 | $84.7M | -54.8% |
| FY2021 | $187.2M | +73.8% |
| FY2020 | $107.8M | - |
| FY2019 | - | - |
| FY2018 | $29.1M | +29.3% |
| FY2017 | $22.5M | +14.7% |
| FY2016 | $19.6M | +74.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026